IPO Search Results for kymera-therapeutics
| Company | Ticker | Business Description | Underwriters | Offer Date |
|---|---|---|---|---|
| Kymera Therapeutics | KYMR | Preclinical biotech developing protein degraders for oncology and immunology. | Morgan Stanley BofA Sec. |
08/20/20 |
| News Results for kymera-therapeutics |
|---|
